Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
05/04/2000 | CA2348835A1 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands |
05/04/2000 | CA2348833A1 Human phospholipases |
05/04/2000 | CA2348827A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | CA2348778A1 Targeted gene modification by parvoviral vectors |
05/04/2000 | CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
05/04/2000 | CA2348730A1 Novel g protein coupled receptor protein and dna thereof |
05/04/2000 | CA2348683A1 Parallel methods for genomic analysis |
05/04/2000 | CA2348634A1 Methods for killing tumor and tumor associated endothelial cells using adenoviral mutants |
05/04/2000 | CA2348563A1 Compositions and methods for treating polycystic kidney disease |
05/04/2000 | CA2348431A1 Interleukin-1 homolog zil1a4 |
05/04/2000 | CA2348430A1 Ovary-specific genes and proteins |
05/04/2000 | CA2348411A1 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
05/04/2000 | CA2348046A1 Lysine-rich statherin protein |
05/04/2000 | CA2348018A1 Rapid recovery of shoots through thin stem slices after preconditioning of micropropagated fruit tree shoots |
05/04/2000 | CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids |
05/04/2000 | CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host |
05/04/2000 | CA2347808A1 New plants formed by microparticle bombardment with uncharacterised dna |
05/04/2000 | CA2347373A1 Recombinant extracellular chitinases and uses thereof |
05/04/2000 | CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand |
05/04/2000 | CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same |
05/04/2000 | CA2347134A1 Maize kin17 orthologues and uses thereof |
05/04/2000 | CA2347128A1 Library of novel "unnatural" natural products |
05/04/2000 | CA2347075A1 Cdna sequence and genomic organization for a 59.4 kda neuronal-specific 7 transmembrane protein (pneu60) |
05/04/2000 | CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
05/04/2000 | CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
05/04/2000 | CA2346768A1 Phytomics: a genomic-based approach to herbal compositions |
05/04/2000 | CA2345902A1 Apomixis conferred by expression of serk interacting proteins |
05/04/2000 | CA2345441A1 Complexity management and analysis of genomic dna |
05/04/2000 | CA2344606A1 Conformation-specific anti-von willebrand factor antibodies |
05/04/2000 | CA2344207A1 Biological material for preparing pharmaceutical compositions for treating mammals |
05/04/2000 | CA2343878A1 Method for generating a gene library |
05/04/2000 | CA2341062A1 Scorpion toxins |
05/04/2000 | CA2316836A1 Identification of novel substrate i-traf of ikk-i kinase |
05/04/2000 | CA2316407A1 Groups of genes expressed in human monocytes and human macrophages |
05/04/2000 | CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
05/03/2000 | EP0997537A2 Assay for detecting modulators of serine/threonine phosphatease activity |
05/03/2000 | EP0997536A2 Method of identifying and detecting eukaryotes using type II topoisomerase gene as indicator |
05/03/2000 | EP0997530A1 Dna polymerase-related factors |
05/03/2000 | EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof |
05/03/2000 | EP0997528A1 Streptomyces avermitilis regulatory genes for increased avermectin production |
05/03/2000 | EP0997477A2 MHC complexes and uses thereof |
05/03/2000 | EP0997476A2 Antibodies to a mammalian Langerhans cell antigen and their uses |
05/03/2000 | EP0997151A2 Method for administering insulinotropic peptides |
05/03/2000 | EP0996858A2 Interactions of atm, atr or dna-pk with p53 |
05/03/2000 | EP0996857A2 Cancer associated nucleic acids and polypeptides |
05/03/2000 | EP0996746A1 Diagnostic method and kit for neuropsychiatric diseases using trinucleotide repeats sequence |
05/03/2000 | EP0996744A2 Methods for rapidly detecting methicillin resistant staphylococci |
05/03/2000 | EP0996743A2 Compositions and methods for detecting vancomycin resistant enterococci by cycling probe reactions |
05/03/2000 | EP0996741A1 Gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries |
05/03/2000 | EP0996739A2 Improvments in gene therapy using compositions comprising a polynucleotide and a nuclease inhibitor or interleukin-10 |
05/03/2000 | EP0996738A1 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
05/03/2000 | EP0996737A1 Semliki forest virus vectors for gene transfer into non-endothelial cardiovascular cells |
05/03/2000 | EP0996736A1 Methods for genetically modifying t cells |
05/03/2000 | EP0996735A2 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus |
05/03/2000 | EP0996734A1 Plant transcription coactivators with histone acetyltransferase activity |
05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
05/03/2000 | EP0996732A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
05/03/2000 | EP0996731A2 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses |
05/03/2000 | EP0996730A1 Nucleic acid vaccines encoding g protein of respiratory syncytial virus |
05/03/2000 | EP0996729A2 Hypersensitive response elicitor fragments and uses thereof |
05/03/2000 | EP0996728A2 IMPROVED ANTI-IgE ANTIBODIES AND METHOD OF IMPROVING POLYPEPTIDES |
05/03/2000 | EP0996727A1 Gene conferring obese phenotype |
05/03/2000 | EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
05/03/2000 | EP0996724A1 Polynucleotides encoding a growth factor-like protein (as amended) |
05/03/2000 | EP0996723A1 Human phosphatidylinositol transfer protein gamma |
05/03/2000 | EP0996722A2 Secreted proteins and polynucleotides encoding them |
05/03/2000 | EP0996721A2 Secreted proteins and polynucleotides encoding them |
05/03/2000 | EP0996719A1 A novel nucleic acid molecule |
05/03/2000 | EP0996718A1 Method for constructing a library using dna shuffling |
05/03/2000 | EP0996717A2 Immunoprotective influenza antigen and its use in vaccination |
05/03/2000 | EP0996716A1 Zggbp1,novel peptides related to bipolar affective disorder type 1, sequences and uses thereof |
05/03/2000 | EP0996715A1 Heterologous expression of proteins by "rescued" vector comprising an intron |
05/03/2000 | EP0996714A2 Method to produce polyketides , polyketides |
05/03/2000 | EP0996713A1 Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin |
05/03/2000 | EP0996712A2 Live attenuated vaccines |
05/03/2000 | EP0996711A1 Cloning and characterization of a human adenylyl cyclase |
05/03/2000 | EP0996710A1 Component of bromelain |
05/03/2000 | EP0996709A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND $g(b)-GLUCANOLYTIC ENZYMES |
05/03/2000 | EP0996707A1 Transgenic animal with recombinant vascular endothelial growth factor b (vegf-b) dna and uses thereof |
05/03/2000 | EP0996705A1 Attachment of unmodified nucleic acids to silanized solid phase surfaces |
05/03/2000 | EP0996639A2 Human antibody against a fusion (poly) peptide or protein presenting a part having at least six histidines |
05/03/2000 | EP0996638A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
05/03/2000 | EP0996637A1 Recombinant protein c and protein s variants |
05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
05/03/2000 | EP0996632A1 Angiostatin fragments and method of use |
05/03/2000 | EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
05/03/2000 | EP0996629A2 Disulfide crosslinked glycoprotein hormone analogs, their preparation and use |
05/03/2000 | EP0996628A2 Mammalian neuro-growth factor like protein |
05/03/2000 | EP0996626A1 Glycine transporter |
05/03/2000 | EP0996468A1 Conjugates of galactose-binding lectins and clostridial neurotoxins as analgesics |
05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
05/03/2000 | EP0996463A2 Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions |
05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
05/03/2000 | EP0996457A1 Fsh-releasing peptides |
05/03/2000 | EP0996453A1 Methods for the inhibition of neuronal activity by local delivery of adenosine |
05/03/2000 | EP0996329A1 Method of genetically transforming banana plants |
05/03/2000 | EP0996328A1 Pollen-based transformation system using solid media |
05/03/2000 | EP0862419B1 Microencapsulated dna for vaccination and gene therapy |
05/03/2000 | EP0812204A4 Codominance-mediated toxins |